Cargando…

Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma

OBJECTIVES: Sarcopenia, a novel concept reflecting the degenerative loss of skeletal muscle mass, is an objective indicator of cancer cachexia. We investigated its role as a prognostic biomarker in advanced urothelial carcinoma (UC) patients. METHODS: This retrospective study consisted of 88 UC pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukushima, Hiroshi, Yokoyama, Minato, Nakanishi, Yasukazu, Tobisu, Ken-ichi, Koga, Fumitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303429/ https://www.ncbi.nlm.nih.gov/pubmed/25612215 http://dx.doi.org/10.1371/journal.pone.0115895

Ejemplares similares

Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy
por: Fukushima, Hiroshi, et al.
Publicado: (2016)

Retroperitoneal Teratoma in an Adult: A Potential Pitfall in the Differential Diagnosis of Adrenal Myelolipoma
por: Kataoka, Madoka, et al.
Publicado: (2016)

Controlling Nutritional Status (CONUT) Score and Sarcopenia as Mutually Independent Prognostic Biomarkers in Advanced Urothelial Carcinoma
por: Une, Minami, et al.
Publicado: (2022)

Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma
por: Fukushima, Hiroshi, et al.
Publicado: (2019)

Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer
por: Fukushima, Hiroshi, et al.
Publicado: (2018)

Novel anatomical apical dissection utilizing puboprostatic “open-collar” technique: Impact on apical surgical margin and early continence recovery
por: Koga, Fumitaka, et al.
Publicado: (2021)

A Case of Renal Pelvic Cancer Complicated by Horseshoe Kidney Treated with RoboSurgeon Gasless Single-Port Retroperitoneoscopic Nephroureterectomy
por: Suzuki, Hiroaki, et al.
Publicado: (2018)

Impact of sarcopenia in bladder preservation therapy for muscle-invasive bladder cancer patients: a narrative review
por: Fukushima, Hiroshi, et al.
Publicado: (2022)

Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
por: Koga, Fumitaka, et al.
Publicado: (2018)

Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti–PD-1 Treatment Efficacy in Urothelial Carcinoma
por: Fukushima, Hiroshi, et al.
Publicado: (2021)

The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma
por: Kang, Ho Won, et al.
Publicado: (2020)

Rectal constriction due to metastasis of urothelial carcinoma of the bladder: A case report
por: Tanabe, Kenji, et al.
Publicado: (2021)

Adverse Prognostic Impact of Diagnostic Ureterorenoscopy in a Subset of Patients with High-Risk Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy
por: Yonese, Ichiro, et al.
Publicado: (2022)

The Prognostic Impact of Histopathological Variants in Patients with Advanced Urothelial Carcinoma
por: Hsieh, Meng-Che, et al.
Publicado: (2015)

Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis
por: Ishii, Akiko, et al.
Publicado: (2020)

Independent verification of circulating miRNA as diagnostic biomarkers for urothelial carcinoma
por: Urabe, Fumihiko, et al.
Publicado: (2022)

Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma
por: Droop, Johanna, et al.
Publicado: (2017)

Urothelial carcinoma of the bladder with cutaneous metastases after robot-assisted radical cystectomy. Case report
por: Yajima, Shugo, et al.
Publicado: (2021)

Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study
por: Fukushima, Hiroshi, et al.
Publicado: (2020)

Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma
por: Nakano, M., et al.
Publicado: (2021)

Antibody-drug conjugates and predictive biomarkers in advanced urothelial carcinoma
por: Fenton, Sarah E., et al.
Publicado: (2023)

Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma
por: Okuyama, Yoshiharu, et al.
Publicado: (2021)

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma
por: Takada, Hitomi, et al.
Publicado: (2018)

Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma
por: Guo, Ya, et al.
Publicado: (2022)

Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder
por: Minato, Akinori, et al.
Publicado: (2018)

Prognostic biomarkers of renal cell carcinoma: Recent advances
por: Kitamura, Hiroshi, et al.
Publicado: (2008)

Prognostic Impact of Sarcopenia in Patients with Advanced Prostate Carcinoma: A Systematic Review
por: de Pablos-Rodríguez, Pedro, et al.
Publicado: (2022)

The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma
por: Nagata, Yujiro, et al.
Publicado: (2020)

A Systematic Review of Serum γ-Glutamyltransferase as a Prognostic Biomarker in Patients with Genitourinary Cancer
por: Takemura, Kosuke, et al.
Publicado: (2021)

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
por: Zeng, Shuxiong, et al.
Publicado: (2017)

PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma
por: Ni, Wenpeng, et al.
Publicado: (2023)

Prognostic analysis of inflammatory response-related genes and biomarkers in patients with urothelial carcinoma of ureter
por: Chen, Huaian, et al.
Publicado: (2023)

ERBB2 Amplification as a Predictive and Prognostic Biomarker in Upper Tract Urothelial Carcinoma
por: Zimpfer, Annette, et al.
Publicado: (2023)

Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
por: Oh, Sooyeon, et al.
Publicado: (2020)

Artificial‐intelligence‐driven discovery of prognostic biomarker for sarcopenia
por: Chung, Heewon, et al.
Publicado: (2021)

Prognostic significance of the albumin-to-globulin ratio for upper tract urothelial carcinoma
por: Omura, Shota, et al.
Publicado: (2020)

A New Form of Specific Targeting Cancer Immunotherapy Using Anti‐tumor Monoclonal Antibody‐conjugated Lymphokine‐activated Killer Cells
por: Shiraiwa, Hiroshi, et al.
Publicado: (1991)

Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma
por: Su, Qisheng, et al.
Publicado: (2020)

Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma
por: Deng, Chao, et al.
Publicado: (2021)

FXYD3: A Promising Biomarker for Urothelial Carcinoma
por: Zhang, ZhongFa, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3ie87tigglo8i3f628510ac0na